Travis Ayers
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
Also affiliated: Arkansas Children's Hospital (2019–2024); North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (2022)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Travis Ayers' research focuses on pediatric gastrointestinal and allergic diseases, with a specific emphasis on inflammatory bowel diseases (IBD) and eosinophilic esophagitis (EoE). He has investigated treatment responses and clinical presentations in young patients, including studies on Tofacitinib for pediatric ulcerative colitis and the impact of atopic status on EoE. Ayers has also explored dietary interventions for IBD, such as N-of-1 diet trials for ulcerative colitis and Crohn's disease. His work includes characterizing eosinophilic colitis in a pediatric cohort and evaluating food elimination as a treatment. Ayers collaborates with Stacie M. Jones, Christina Tootle, Robbie Pesek, and Dieu Doan at the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications.
Metrics
- h-index: 5
- Publications: 7
- Citations: 112
Selected Publications
-
Dupilumab Failures in Pediatric and Adolescent Eosinophilic Esophagitis: A Retrospective Cohort Study (2026)
-
Impact of Atopic Status on Clinical Presentation and Treatment Response in Pediatric Patients With Eosinophilic Esophagitis (2024)
-
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience (2024)
-
Oral Vancomycin as an Adjuvant Treatment in IBD (2019)
Collaboration Network
Top Collaborators
- Impact of Atopic Status on Clinical Presentation and Treatment Response in Pediatric Patients With Eosinophilic Esophagitis
- Dupilumab Failures in Pediatric and Adolescent Eosinophilic Esophagitis: A Retrospective Cohort Study
- Impact of Atopic Status on Clinical Presentation and Treatment Response in Pediatric Patients With Eosinophilic Esophagitis
- Dupilumab Failures in Pediatric and Adolescent Eosinophilic Esophagitis: A Retrospective Cohort Study
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
Similar Researchers
Based on overlapping research topics